CHOP researchers have integrated environmental, genetic and imaging data to better understand which factors might be clinically relevant in psychiatric and cognitive outcomes.

While telemedicine appeared to be effective in 95% of cases, some younger patients and those with neuromuscular disorders still required in-person visits.

Prestigious award recognizes Dr. High’s contribution to improving children’s health through her gene therapy research.

CHOP researchers have developed new software called CancerVar, which helps researchers assess the clinical impacts of over 13 million somatic cancer mutations.

Children and young adults experienced a decline in cardiopulmonary exercise performance during the COVID-19 pandemic.

CHOP researchers found neighborhood characteristics were associated with higher rates of SARS-CoV-2 in pregnancy during the prevaccination era of the COVID-19 pandemic

Two Oncologists within the Cancer Center were recognized at the 2022 ASPHO Conference.

The mitochondrial genetic status of patients should be considered when recommending exercise as therapy.

The findings were published in JAMA Network Open.

CHOP CVI will be led by Daniel P. Kelly, MD, current Director of the Penn Cardiovascular Institute.